Related Experiment Video
Updated: Jul 31, 2026
12:38
Titration ELISA as a Method to Determine the Dissociation Constant of Receptor Ligand Interaction
Published on: February 15, 2018
Deoxycorticosterone-adenine interactions in a crystalline complex
Science (New York, N.Y.)
|December 12, 1975
Summary
This study presents the first crystal structure of a deoxycorticosterone-adenine complex. The findings reveal specific hydrogen bonds and molecular packing, suggesting potential in vivo interactions between steroids and DNA components.
Area of Science:
- Biochemistry
- Crystallography
- Molecular Biology
Background:
- Steroids and DNA are crucial biomolecules with complex interactions.
- Understanding these interactions at a molecular level is vital for biological and medical research.
Purpose of the Study:
- To characterize the first crystalline complex of a steroid and a DNA component.
- To elucidate the specific molecular interactions within this complex using X-ray crystallography.
Main Methods:
- Single crystal X-ray diffraction analysis was employed.
- The crystal structure of deoxycorticosterone-adenine monohydrate was determined.
Main Results:
- The study successfully crystallized and analyzed a complex of deoxycorticosterone (a steroid) and adenine (a DNA component).
- Specific hydrogen bonds were identified between the steroid's side chain and the adenine molecule (O(20)-N(6) and O(21)-N(1)).
- Analysis revealed adenine molecules positioned over the steroid's delta4-3-one region, indicating specific packing arrangements.
Conclusions:
- The crystal structure provides the first direct evidence of how steroids and DNA components can interact at a molecular level.
- These solid-state observations offer insights into potential in vivo mechanisms of steroid-nucleic acid interactions.
Related Concept Videos
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...